Study Attempts to Create New Beta Cells

Procter & Gamble Pharmaceuticals is sponsoring a new study on the safety and efficacy of INGAP-peptide.

Researchers are currently recruiting new patients to attempt to create new beta cells in the pancreas and to restore the ability to produce insulin in people with type 1 diabetes.

The phase 2 study is interventional, randomized, double blinded, and placebo controlled.


At present, the type 1 arm of the study is full. However, there is still a need for some type 2s who would like to take part in the study.

Requirements for type 2s who wish to participate are:

  • You must be between 35 and 70 years old
  • You must have an A1C between 6.5% and 10%
  • You must have a fasting C-peptide of less than 0.3 ng/ml

Clinical Trials-National Institutes of Health, November 2003

Leave a Reply

Your email address will not be published. Required fields are marked *

Time limit is exhausted. Please reload CAPTCHA.